Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
198.12B
Market cap198.12B
Price-Earnings ratio
10.54
Price-Earnings ratio10.54
Dividend yield
2.74%
Dividend yield2.74%
Average volume
13.01M
Average volume13.01M
High today
$44.99
High today$44.99
Low today
$44.35
Low today$44.35
Open price
$44.74
Open price$44.74
Volume
5.51M
Volume5.51M
52 Week high
$81.44
52 Week high$81.44
52 Week low
$35.12
52 Week low$35.12

NVO News

Bloomberg 2h
Brazil Clears First Generic Copy of Novo Nordisk’s Ozempic Shot - Bloomberg.com

...

Brazil Clears First Generic Copy of Novo Nordisk’s Ozempic Shot - Bloomberg.com
Nasdaq 8h
Prediction: These 2 Obesity Drug Stocks Could Double in 2026

Key Points The weight loss opportunity is a significant one for companies and investors -- and companies involved have seen their shares soar. Analysts predic...

Prediction: These 2 Obesity Drug Stocks Could Double in 2026
Simply Wall St 17h
Oral Wegovy And Cancer Signals Reframe Novo Nordisk GLP 1 Opportunity

EMA committee issues positive opinion on EU marketing authorisation for oral Wegovy (semaglutide) for weight management, including cardiovascular outcomes. Ora...

Oral Wegovy And Cancer Signals Reframe Novo Nordisk GLP 1 Opportunity

Analyst ratings

57%

of 37 ratings
Buy
35.1%
Hold
56.8%
Sell
8.1%

More NVO News

The Motley Fool 17h
Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

The introduction of GLP-1 drugs has revolutionized the way the world looks at weight loss. Taking a shot or a pill to curb one's appetite and lose weight is clo...

Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro
Nasdaq 1d
CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity

Novo Nordisk NVO announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has issued a positive opinio...

CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity
Simply Wall St 4d
Assessing Novo Nordisk Valuation After Recent Share Price Volatility

Advertisement Recent performance snapshot Novo Nordisk (NYSE:NVO) has drawn attention after a mixed run in the stock, with a gain of about 15% over the past m...

Assessing Novo Nordisk Valuation After Recent Share Price Volatility
TipRanks 4d
Novo Nordisk Wins CHMP Backing for High-Dose Wegovy Single-Dose Pen in EU

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, person...

TipRanks 4d
Novo Nordisk Expands Obesity Reach With AMAZE 3 Sleep Apnoea Trial

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask S...

TipRanks 4d
Novo Nordisk’s AMAZE 4 Trial Targets Obesity and Sleep Apnea for Next Growth Leg

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask S...

TipRanks 4d
Studies suggest Ozempic, Mounjaro may slow tumor progression, WSJ reports

New studies suggest GLP-1 drugs such as Ozempic and Mounjaro, developed by Novo Nordisk (NVO) and Eli Lilly (LLY), may significantly improve cancer outcomes by...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.